Reumatología Clínica

Reumatología Clínica (English Edition)

ISSN: 2173-5743

Reumatología Clínica is the official publication of scientific Spanish Society of Rheumatology (SER) and the Mexican College of Rheumatology (CMR). Reumatología Clínica publishes original research papers, editorials, reviews, case reports and pictures. Published studies are primarily clinical and epidemiological research but also basic.

Reumatología Clínica has received its first journal Impact Factor (JCR) in 2023.
Instructions for authors - Submit an article

Indexed in:

Web of Science, Index Medicus/MEDLINE, Scopus, ESCI (Emerging Sources Citation Index), IBECS, IME, CINAHL

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2022

1.5

Citescore

CiteScore measures average citations received per document published.

Citescore 2022

2.3

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2022

0.323

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2022

0.473

View more metrics

Open Access Option

Journal Information

Previous Issue | Next Issue

Issue

Vol. 20. Issue 3.

Pages 117-172 (March 2024)

Sumario en español

Original articles

Performance of adenosine deaminase in synovial fluid for the diagnosis of tuberculous arthritis: A systematic review and meta-analysis

Juan Carlos Cortes-Quiroz, Jose Bernal, Jose Rosas, Javier Ena

Reumatol Clin. 2024;20:117-22

Is the use of secukinumab after anti-TNF therapy greater than expected for the risk of developing inflammatory bowel disease?

Fatih Albayrak, Mustafa Gür, Ahmet Karataş, Süleyman Serdar Koca, Bünyamin Kısacık

Reumatol Clin. 2024;20:123-7

The impact of COVID-19 and other factors on the usage status of the biologic drug therapies for rheumatoid arthritis: A study from Vietnam

Hai-Binh Bui, Hong-Thinh Lai, Thanh-Lam Nguyen, Thuy-Duong Vu, Nhat-Le Bui, Van-Hung Nguyen, Thi-To-Chau Tran, Thi-Phuong-Thuy Nguyen, ... Dinh-Toi Chu

Reumatol Clin. 2024;20:128-35

Original articles

Ibero-american rheumatology

Elderly-onset rheumatoid arthritis receives less aggressive therapies than young-onset rheumatoid arthritis in an Argentinian cohort

Nicolás Pérez, María de Los Ángeles Gargiulo, Marina Khoury, Lorena Suárez, María de los Ángeles Correa, Mariana Pera, Natali Saravia, Graciela Gómez

Reumatol Clin. 2024;20:136-41

External validation of the 2017 ACR/EULAR classification criteria for inflammatory myopathies in a Mexican cohort: Role of autoantibodies in the diagnosis and classification of patients with inflammatory myopathies

Grisel Guadalupe Sánchez-Mendieta, David Vega-Morales, Miguel Ángel Villarreal-Alarcón, Jesús Eduardo Compean-Villegas, Ilse Andrea Moreno-Arquieta, Dionicio Ángel Galarza-Delgado

Reumatol Clin. 2024;20:142-6

Brief report

Usefulness of ultrasound in clinical decision-making in rheumatology clinical practice: A single-center longitudinal study

Marta Serrano-Warleta, Aliuska Palomeque-Vargas, Rosa Manzo, Boris Blanco-Cáceres, Mónica Vazquez-Díaz, Carlos Guillen-Astete

Reumatol Clin. 2024;20:147-9

Cardiovascular event in a cohort of rheumatoid arthritis patients in Castilla-La Mancha: Utility of carotid ultrasound

Marco Aurelio Ramírez Huaranga, David Velasco Sánchez, Luis Ángel Calvo Pascual, David Castro Corredor, María Dolores Mínguez Sánchez, Verónica Salas Manzanedo, Eva Revuelta Evrard, Rocío Arenal López, ... Marcos Paulino Huertas

Reumatol Clin. 2024;20:150-4